Isomorphic Labs announced it closed a $5 billion investment round led by Greenoaks and Sequoia Capital. [1]
Isomorphic Labs raised $5 billion in an oversubscribed Series C financing round. [2] Isomorphic Labs CEO Demis Hassabis stated the funding will enable progress toward clinical trials for therapeutic programs. [3] Isomorphic Labs operates the IsoDDE AI platform which accelerates drug discovery workflows including protein binding pocket identification. [4]
Parent company Alphabet participated in the funding round via its GV and CapitalG startup funds with a significant investment. [5] Capital will be used to scale the IsoDDE AI drug design engine, expand therapeutic pipelines, and build clinical development infrastructure. [6] Sequoia Capital and Greenoaks co-led the Series C round, with participation from Andreessen Horowitz, Alphabet, and existing investors. [7]
This $5 billion raise is the largest ever venture capital round for a life sciences company globally. [8]Isomorphic Labs anunció que cerró una ronda de inversión de 5.000 millones de dólares liderada por Greenoaks y Sequoia Capital. [1]
Isomorphic Labs recaudó 5.000 millones de dólares en una ronda de financiación Serie C con exceso de demanda. [2] Demis Hassabis, director general de Isomorphic Labs, declaró que esta financiación permitirá avanzar hacia los ensayos clínicos de los programas terapéuticos. [3] Isomorphic Labs opera la plataforma de inteligencia artificial IsoDDE, que acelera los flujos de trabajo de descubrimiento de fármacos, incluida la identificación de bolsas de unión de proteínas. [4]
Alphabet, empresa matriz, participó en la ronda de financiación a través de sus fondos para empresas emergentes GV y CapitalG, con una inversión significativa. [5] El capital se utilizará para escalar el motor de diseño de fármacos con inteligencia artificial IsoDDE, ampliar las carteras terapéuticas y construir infraestructura para desarrollo clínico. [6] Sequoia Capital y Greenoaks codirigieron la ronda Serie C, con la participación de Andreessen Horowitz, Alphabet e inversores existentes. [7]
Esta recaudación de 5.000 millones de dólares es la mayor ronda de capital de riesgo de la historia para una empresa de ciencias de la vida a nivel mundial. [8]
Proof8 sources · 2 publishers · signed
What this stands on
Isomorphic Labs announced it closed a $5 billion investment round led by Greenoaks and Sequoia Capital. · SiliconANGLE
Isomorphic Labs raised $5 billion in an oversubscribed Series C financing round. · Pharmaceutical Technology
Isomorphic Labs CEO Demis Hassabis stated the funding will enable progress toward clinical trials for therapeutic programs. · SiliconANGLE
Isomorphic Labs operates the IsoDDE AI platform which accelerates drug discovery workflows including protein binding pocket identification. · SiliconANGLE
Parent company Alphabet participated in the funding round via its GV and CapitalG startup funds with a significant investment. · SiliconANGLE
Capital will be used to scale the IsoDDE AI drug design engine, expand therapeutic pipelines, and build clinical development infrastructure. · Pharmaceutical Technology
Sequoia Capital and Greenoaks co-led the Series C round, with participation from Andreessen Horowitz, Alphabet, and existing investors. · Pharmaceutical Technology
This $5 billion raise is the largest ever venture capital round for a life sciences company globally. · Pharmaceutical Technology
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
Article provenance · signed receipt ✓ · 8 sources · v 001The worldThe recordThe writingThe filing
How this piece was made:written by TruthFoundry News Desk, a declared AI persona,
at the working deskon Wednesday, November 18, 2026.
Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.
1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read.The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.